Company: PBH
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001295947-25-000039
Chunk: 13

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Item 2
Chunk 13
---
.6 million decrease was primarily attributable to a decrease in sales in the Eye & Ear Care category, partly offset by an increase in sales in the Dermatologicals category.

23

Gross Profit

The following table presents our gross profit and gross profit as a percentage of total segment revenues, by segment for each of the periods presented.

Three Months Ended September 30, (In thousands)Increase (Decrease)Gross Profit2025%2024%Amount%North American OTC Healthcare$128,408 55.6 $132,029 55.1 $(3,621)(2.7)International OTC Healthcare23,171 53.4 25,353 57.7 (2,182)(8.6)$151,579 55.3 $157,382 55.5 $(5,803)(3.7)

Gross profit for the three months ended September 30, 2025 decreased $5.8 million, or 3.7%, when compared with the three months ended September 30, 2024.  As a percentage of total revenues, gross profit decreased to 55.3% during the three months ended September 30, 2025 from 55.5% during the three months ended September 30, 2024, primarily due to the decrease in revenue and the decrease in International OTC Healthcare segment gross margins.

North American OTC Healthcare Segment

Gross profit for the North American OTC Healthcare segment decreased $3.6 million, or 2.7%, during the three months ended September 30, 2025 versus the three months ended September 30, 2024.  As a percentage of North American OTC Healthcare revenues, gross profit increased to 55.6% during the three months ended September 30, 2025 from 55.1% during the three months ended September 30, 2024, primarily due to a more favorable product mix.

International OTC Healthcare Segment

Gross profit for the International OTC Healthcare segment decreased $2.2 million, or 8.6%, during the three months ended September 30, 2025 versus the three months ended September 30, 2024.  As a percentage of International OTC Healthcare revenues, gross profit decreased to 53.4% during the three months ended September 30, 2025 from 57.7% during the three months ended September 30,